- Category
- Micro (2021-22)
- Udyam number
- UDYAM-TN-02-0084698

Avanz Pharma Private Limited
About Avanz Pharma Private Limited
Data last updated:
Avanz Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 05 August 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24233TN2021PTC145300.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Nepolian Bounapart Deivanayagam and Ramasamy Sivasubramanian.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 104B And 105 Vgn Shanthi Nagar Mahatma Gandhi Street Ambattur, Chennai, Tamil Nadu, India – 600058.
As per the financials filed for FY 2025, the company reported a revenue of ₹21.32 Lakh, a decline of 43% compared to the previous year. For the same year it recorded a net loss of ₹6.31 Lakh (net margin -29.6%) and EBITDA of -₹4.11 Lakh (EBITDA margin -19.3%). Revenue has grown at a compounded annual rate (CAGR) of 52% over three years.
As per MCA filings, the company has open charges of ₹15 Lakh on record.
Avanz Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0084698).
Company details
Recognitions & Rankings of Avanz Pharma
Contact details
Avanz Pharma Private Limited's registered office is in Chennai, Tamil Nadu.
- Registered AddressPlot No. 104B And 105 Vgn Shanthi Nagar Mahatma Gandhi Street Ambattur, Chennai, Tamil Nadu, India – 600058
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Avanz Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Avanz Pharma Private Limited, buy the company report.
Financials of Avanz Pharma Private Limited
FY 2025 filings availableAvanz Pharma Private Limited reported revenue of ₹21.32 Lakh (down 43% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 43% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 52%. EBITDA fell 541% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹4.11 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹6.31 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -19.3% | |||
| Net Profit Margin | -29.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Avanz Pharma Private Limited, buy the company report.
Board of directors of Avanz Pharma Private Limited
Avanz Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nepolian Bounapart Deivanayagam | Director | 05 Aug 2021 | 5 Years 2 Months | Current |
| Ramasamy Sivasubramanian | Director | 05 Aug 2021 | 5 Years 2 Months | Current |
Peer comparison
Avanz Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Maxxon Lubricants Private Limited | ₹21.33 Lakh (FY 2025) | 3.0% | Ahmedabad, Gujarat, India | |||
| Vivavera Private Limited | ₹21.33 Lakh (FY 2023) | 47.0% | Surat, Gujarat, India | |||
| Dalela Business Solutions Private Limited | ₹21.33 Lakh (FY 2016) | 110.0% | Lucknow, Uttar Pradesh, India | |||
| Mercato Marketing India Private Limited | ₹21.33 Lakh (FY 2020) | Kottarakkara, Kerala, India | ||||
| Ritudhara Marketing Private Limited | ₹21.33 Lakh (FY 2018) | -30.0% | Kolkata, West Bengal, India | |||
| Avanz Pharma Private Limitedthis company | ₹21.32 Lakh (FY 2025) | -₹6.31 Lakh | -29.6% | -43.0% | Chennai, Tamil Nadu, India | |
| Infingrow Smart Technologies Private Limited | ₹21.32 Lakh (FY 2024) | -52.0% | Chennai, Tamil Nadu, India | |||
| Exact MFD Private Limited | ₹21.32 Lakh (FY 2020) | 55.0% | Chennai, Tamil Nadu, India | |||
| Kops International Limited | ₹21.32 Lakh (FY 2025) | -50.0% | Faridabad, Haryana, India | |||
| Anmol Merchants Private Limited | ₹21.31 Lakh (FY 2025) | 4.0% | Kolkata, West Bengal, India | |||
| Premsudha Exports Private Limited | ₹21.31 Lakh (FY 2025) | -21.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Avanz Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Aug 2023 | 100792665 | Others | ₹15 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Avanz Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Avanz Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Avanz Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Avanz Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Nepolian Bounapart Deivanayagam was appointed as Director on 05 Aug 2021.
Frequently asked questions
Avanz Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 05 August 2021 (5+ years old) and is registered under CIN U24233TN2021PTC145300.
Avanz Pharma has 2 current directors:
- Nepolian Bounapart Deivanayagam - Director
- Ramasamy Sivasubramanian - Director
The latest financial statements of Avanz Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Avanz Pharma is U24233TN2021PTC145300. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Avanz Pharma was incorporated on 05 August 2021, making it 5+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Avanz Pharma by revenue are Maxxon Lubricants Private Limited, Vivavera Private Limited, Dalela Business Solutions Private Limited, Mercato Marketing India Private Limited, Ritudhara Marketing Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Nepolian Bounapart Deivanayagam was appointed as Director on 05 Aug 2021. Ramasamy Sivasubramanian was appointed as Director on 05 Aug 2021.
Yes, Avanz Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0084698).
The registered office of Avanz Pharma is at Plot No. 104B And 105 Vgn Shanthi Nagar Mahatma Gandhi Street Ambattur, Chennai, Tamil Nadu, India – 600058.
Avanz Pharma operates in the chemicals industry, in the manufacturing segment.
Avanz Pharma has open charges of ₹15 Lakh and no satisfied charges on record as per latest MCA filings.

